Cargando…

Conservative Treatment of Acute Colonic Diverticulitis

PURPOSE OF REVIEW: Since the treatment of acute diverticulitis has become more conservative over the last years, knowledge of conservative treatment strategies is increasingly important. RECENT FINDINGS: Several treatment strategies that previously have been imposed as routine treatment are now obso...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, S. T., Rottier, S. J., van Geloven, A. A. W., Boermeester, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610668/
https://www.ncbi.nlm.nih.gov/pubmed/28942590
http://dx.doi.org/10.1007/s11908-017-0600-y
_version_ 1783265798399197184
author van Dijk, S. T.
Rottier, S. J.
van Geloven, A. A. W.
Boermeester, M. A.
author_facet van Dijk, S. T.
Rottier, S. J.
van Geloven, A. A. W.
Boermeester, M. A.
author_sort van Dijk, S. T.
collection PubMed
description PURPOSE OF REVIEW: Since the treatment of acute diverticulitis has become more conservative over the last years, knowledge of conservative treatment strategies is increasingly important. RECENT FINDINGS: Several treatment strategies that previously have been imposed as routine treatment are now obsolete. Uncomplicated diverticulitis patients can be treated without antibiotics, without bed rest, and without dietary restrictions; and a selected group of patients can be treated as outpatients. Also, patients with isolated pericolic extraluminal air can be treated conservatively as well. Whereas some patient subgroups have been suggested to suffer from a more virulent disease course or higher recurrence rates, current evidence does not support all traditional understandings. Patients on immunosuppression or non-steroidal anti-inflammatory drugs seem to have a higher risk of complicated diverticulitis, but young patients do not. Data on the risk of recurrent diverticulitis in young patients is conflicting but the risk seems comparable to elderly patients. Besides the traditional treatments, several new treatment strategies have emerged but have failed thus far. Mesalazine does not have any beneficial effect on preventing recurrent diverticulitis based on current literature. Rifaximin and probiotics have been studied insufficiently in acute diverticulitis patients to conclude on their efficacy. SUMMARY: This review provides an overview of recent developments in conservative treatment strategies of acute diverticulitis and discusses the latest evidence on patient subgroups that have been suggested to suffer from an aberrant disease course.
format Online
Article
Text
id pubmed-5610668
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-56106682017-10-10 Conservative Treatment of Acute Colonic Diverticulitis van Dijk, S. T. Rottier, S. J. van Geloven, A. A. W. Boermeester, M. A. Curr Infect Dis Rep Intra-abdominal Infections, Hepatitis, and Gastroenteritis (T Steiner, Section Editor) PURPOSE OF REVIEW: Since the treatment of acute diverticulitis has become more conservative over the last years, knowledge of conservative treatment strategies is increasingly important. RECENT FINDINGS: Several treatment strategies that previously have been imposed as routine treatment are now obsolete. Uncomplicated diverticulitis patients can be treated without antibiotics, without bed rest, and without dietary restrictions; and a selected group of patients can be treated as outpatients. Also, patients with isolated pericolic extraluminal air can be treated conservatively as well. Whereas some patient subgroups have been suggested to suffer from a more virulent disease course or higher recurrence rates, current evidence does not support all traditional understandings. Patients on immunosuppression or non-steroidal anti-inflammatory drugs seem to have a higher risk of complicated diverticulitis, but young patients do not. Data on the risk of recurrent diverticulitis in young patients is conflicting but the risk seems comparable to elderly patients. Besides the traditional treatments, several new treatment strategies have emerged but have failed thus far. Mesalazine does not have any beneficial effect on preventing recurrent diverticulitis based on current literature. Rifaximin and probiotics have been studied insufficiently in acute diverticulitis patients to conclude on their efficacy. SUMMARY: This review provides an overview of recent developments in conservative treatment strategies of acute diverticulitis and discusses the latest evidence on patient subgroups that have been suggested to suffer from an aberrant disease course. Springer US 2017-09-23 2017 /pmc/articles/PMC5610668/ /pubmed/28942590 http://dx.doi.org/10.1007/s11908-017-0600-y Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Intra-abdominal Infections, Hepatitis, and Gastroenteritis (T Steiner, Section Editor)
van Dijk, S. T.
Rottier, S. J.
van Geloven, A. A. W.
Boermeester, M. A.
Conservative Treatment of Acute Colonic Diverticulitis
title Conservative Treatment of Acute Colonic Diverticulitis
title_full Conservative Treatment of Acute Colonic Diverticulitis
title_fullStr Conservative Treatment of Acute Colonic Diverticulitis
title_full_unstemmed Conservative Treatment of Acute Colonic Diverticulitis
title_short Conservative Treatment of Acute Colonic Diverticulitis
title_sort conservative treatment of acute colonic diverticulitis
topic Intra-abdominal Infections, Hepatitis, and Gastroenteritis (T Steiner, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610668/
https://www.ncbi.nlm.nih.gov/pubmed/28942590
http://dx.doi.org/10.1007/s11908-017-0600-y
work_keys_str_mv AT vandijkst conservativetreatmentofacutecolonicdiverticulitis
AT rottiersj conservativetreatmentofacutecolonicdiverticulitis
AT vangelovenaaw conservativetreatmentofacutecolonicdiverticulitis
AT boermeesterma conservativetreatmentofacutecolonicdiverticulitis